Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial...

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Neuregulin-1 (NRG1) is a crucial growth factor in brain development and function.
• NRG1 signaling influences brain microvascular endothelial cells, modulating permeability.
• Neuroinflammation involves increased endothelial permeability, impacting brain function.

Purpose of the Study:

• To investigate the specific pathways by which the NRG1-β isoform affects Interleukin-1 beta (IL-1β)-induced endothelial permeability.
• To elucidate the molecular mechanisms underlying NRG1-β's protective role in brain microvasculature during neuroinflammation.

Main Methods:

• Utilized transendothelial electrical resistance and dextran-40 extravasation assays to measure endothelial barrier function.
• Investigated the role of RhoA activation and myosin light chain (MLC) phosphorylation in NRG1-β's mechanism.
• Employed AG825, an erbB2-associated tyrosine kinase inhibitor, to assess receptor involvement.

Main Results:

• NRG1-β enhanced endothelial barrier function and reduced IL-1β-induced hyperpermeability.
• NRG1-β signaling inhibited IL-1β-induced RhoA activation and MLC phosphorylation.
• AG825 partially blocked the protective effects of NRG1-β, indicating erbB2 pathway involvement.

Conclusions:

• NRG1-β signaling preserves brain microvascular barrier integrity during neuroinflammation.
• The mechanism involves inhibiting the RhoA/MLC pathway, which is activated by IL-1β.
• NRG1-β represents a potential therapeutic target for neuroinflammatory conditions affecting the brain vasculature.